Search Results

You are looking at 1 - 1 of 1 items for

  • Author: M. A. Ghatei x
  • Refine by access: Content accessible to me x
Clear All Modify Search
B M McGowan Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by B M McGowan in
Google Scholar
PubMed
Close
,
J S Minnion Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by J S Minnion in
Google Scholar
PubMed
Close
,
K G Murphy Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by K G Murphy in
Google Scholar
PubMed
Close
,
D Roy Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by D Roy in
Google Scholar
PubMed
Close
,
S A Stanley Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by S A Stanley in
Google Scholar
PubMed
Close
,
W S Dhillo Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by W S Dhillo in
Google Scholar
PubMed
Close
,
J V Gardiner Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by J V Gardiner in
Google Scholar
PubMed
Close
,
M A Ghatei Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by M A Ghatei in
Google Scholar
PubMed
Close
, and
S R Bloom Department of Diabetes and Endocrinology, Section of Investigative Medicine, Molecular Genetics, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, London

Search for other papers by S R Bloom in
Google Scholar
PubMed
Close

Relaxin-3 is a member of the insulin superfamily. It is expressed in the nucleus incertus of the brainstem, which has projections to the hypothalamus. Relaxin-3 binds with high affinity to RXFP1 and RXFP3. RXFP3 is expressed within the hypothalamic paraventricular nucleus (PVN), an area central to the stress response. The physiological function of relaxin-3 is unknown but previous work suggests a role in appetite control, stimulation of the hypothalamic–pituitary–gonadal axis and stress. Central administration of relaxin-3 induces c-fos expression in the PVN and increases plasma ACTH levels in rats. The aim of this study was to investigate the effect of central administration of human relaxin-3 (H3) on the hypothalamic–pituitary–adrenal (HPA) axis in male rodents in vivo and in vitro. Intracerebroventricular (i.c.v) administration of H3 (5 nmol) significantly increased plasma corticosterone at 30 min following injection compared with vehicle. Intra-PVN administration of H3 (1.8–1620 pmol) significantly increased plasma ACTH at 1620 pmol H3 and corticosterone at 180–1620 pmol H3 at 30 min following injection compared with vehicle. The stress hormone prolactin was also significantly raised at 15 min post-injection compared with vehicle. Treatment of hypothalamic explants with H3 (10–1000 nM) stimulated the release of corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP), but H3 had no effect on the release of ACTH from in vitro pituitary fragments. These results suggest that relaxin-3 may regulate the HPA axis, via hypothalamic CRH and AVP neurons. Relaxin-3 may act as a central signal linking nutritional status, reproductive function and stress.

Free access